AM-Pharma raised €12M in a Series D+ round in Sep 2014. The company is based in Utrecht, Netherlands. Investors in the round: Abbvie Biotech Ventures, Gilde Healthcare, Inventages Venture Capital and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €12M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
